Hot Products

Laricitrin
Catalog No: CFN70400

Laricitrin is a novel flavonoid ABCG2 inhibitor, it suppresses certain factors and decreases the progression of lung cancer cells that are promoted by BaP in the lung cancer tumor microenvironment. Laricitrin could be an efficacious immunoadjuvant and have a synergistic effect when combined with chemotherapy.

Laricitrin 3-O-glucoside
Catalog No: CFN80175

Laricitrin 3-O-glucoside has antioxidant property.

Lasiocarpine
Catalog No: CFN00289

Lasiocarpine has antimitotic action,it has hepatocarcinogenicity, the effect can be better explained by its strong selection (promotion) influence on initiated hepatocytes, rather than by its very weak initiating activity.

Lasiocarpine N-oxide
Catalog No: CFN00290

Lasiocarpine-N-oxide shows antimicrobial activity against selected pathogenic bacteria and fungi.

L-Asparagine
Catalog No: CFN70188

L-asparaginase is effective in suppressing cellular immunity and inducing remission in patients with acute lymphocytic leukemia, mainly a non-B-cell disease.The enhancing action of L-asparagine upon insulin release evoked by L-leucine is attributable to an increased generation rate of cytosolic NADPH rather than any increase in nutrients oxidation.

L-Aspartic acid
Catalog No: CFN70148

L-Aspartic acid induces a region of negative slope conductance in the current-voltage relationship of cultured spinal cord neurons. It could as the amino donor.

Lathyrol
Catalog No: CFN98115

Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance, and is used for cancer treatment.

Latifoline
Catalog No: CFN00266

Reference standards.

Lauric acid
Catalog No: CFN90493

Lauric acid is a middle chain-free fatty acid with strong bactericidal properties. The EC50s for P. acnes, S.aureus, S. epidermidis, are 2, 6, 4 μg/mL, respectively. Lauric acid displays preferential antineoplastic property, including induction of apoptosis in a CRC cell line.

Laurifoline
Catalog No: CFN97205

Laurifoline is a potential NF-κB inhibitor and a potential β2 -adrenegic receptor agonist, it can not only inhibit Pseudomonas aeruginosa PAK strain-induced inflammatory responses via a negative regulation of the Braf protein that participates in MAPK signaling pathway but also activate the β2 -adrenegic receptor. Laurifoline may show anti-HBV activities in vitro using the HBV transfected Hep G2.2.15 cell line.